Nutraceutical Clinical Laboratories International, Inc., (OTC PK: NCCL)

Dear Reader:

You may recall today's featured company from our profile on December 20, 2002 (click here).  Since that time NCCL has continued to progress, adding industry leaders to its operations and R&D teams and finding new applications for its proprietary food and beverage preservative NuPreserv™, an FDA cleared product that delivers significant increases in shelf life over current chemical preservatives. 

Today NCCL has breaking news that we know you will find interesting. 
 

* Breaking News * Breaking News* Breaking News *

ST. PETERSBURG, Fla., Feb. 4 /PRNewswire-FirstCall/ -- Nutraceutical Clinical Laboratories International, Inc. (OTC Pink Sheets: NCCL), a preservative and nutraceutical products company, today announced that it has appointed Samuel E. Hudgins, a financial services executive and consultant, and Kathy A. Joiner, a senior commercial banker, to its Board of Directors.

"Sam and Kathy are two great additions to our Board," said Gary L.Harrison, Chairman and Chief Executive Officer of NCCL.  "They both are skilled executives with impeccable credentials, and the Board will benefit from their experience and judgment.  The Board's strong commitment to NCCL's future is evidenced by the more than $3 million we have collectively invested in the Company over the past 18 months."

Mr. Hudgins serves on the Board of Directors and Executive Committee of Atlantic American Corporation, an insurance holding company.  He also provides management and financial advisory services to a variety of clients through Hudgins Consulting, a firm he formed in 1997.  Previously, Mr. Hudgins was a member of the Board of Directors of The Wachovia Funds from 1992 until 2002.  He also was President of Atlantic American and Chairman of its three insurance companies.  Mr. Hudgins also served as Vice Chairman and Chief Executive Officer of Rhodes, Inc., a retail furniture chain subsidiary of Atlantic American.  He began his career at Arthur Andersen in 1951, where he held a number of senior leadership positions prior to his retirement in 1986.  Ms. Joiner is the President of the Thomasville, Georgia division of SunTrust Bank, one of the largest commercial banking organizations in the U.S. In this position, which she has held since 1999, Ms. Joiner is responsible for managing the division's operations and growing its market share.  Prior to joining SunTrust, Ms. Joiner worked at The Citizens and Southern National Bank, which merged in 1991 with NationsBank, which is now known as Bank of America.  Ms. Joiner is active in many civic, charitable and professional organizations, and recently was selected as an Honorary Member of the President's Advisory Committee for Small business.

The Company also announced that its founder, Paul L. Simmons, has resigned from its Board to pursue other interests.  NCCL's Board thanked Mr. Simmons for his contributions to the Company.  Mr. Hudgins and Ms. Joiner join the following executives on NCCL's Board of Directors (more information about each Board Member is available on the Company's Web site at http://www.nutradata.com ):

     * Gary L. Harrison, Chairman and Chief Executive Officer
     * William J. Catacosinos, Ph.D., Vice Chairman
     * Robert Gillham, Director
     * Richard Goldfarb, M.D., Director and President and Chief Operating
       Officer of NCCL's Medical Division
     * Philip E. Pearce, Director
     * George J. Sideris, Director

About Nutraceutical Clinical Laboratories International, Inc.
Incorporated in 1999, Nutraceutical Clinical Laboratories International, Inc. is a company that researches, manufactures and markets preservative and nutraceutical products.  Based in St. Petersburg, Florida, the Company has a Preservative Division and a Medical Division, which includes the wholly owned subsidiary Health Care Direct Services, Inc. (HCD).  The Preservative unit focuses on developing, manufacturing and marketing NuPreserv(TM), a preservative that extends the shelf life of food products and beverages.  The Medical unit focuses on developing NuPreserv's medical applications and manufacturing and distributing HCD's nutraceutical products to more than 20,000 independent and chain-store pharmacies across the U.S.  More information about Nutraceutical Clinical Laboratories International, Inc. is available on the Company's Web site at http://www.nutradata.com .

CAUTIONARY NOTE: Statements contained in this press release that are not historical facts are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995.  All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from the forward-looking statements contained in this release and which may affect the Company's prospects in general.

SOURCE Nutraceutical Clinical Laboratories International, Inc.
Web Site: http://www.nutradata.com 
 

NuPreserv Key Markets

The following is a list of markets that NCCL is currently working with, either using NuPreserv™ or conducting shelf-life tests. 

• Bakery Market - Currently NuPreserv is in over 300 sku's 
• Beverage Market - currently performing tests Juices, Teas, Soft Drinks 
• Poultry Market - currently performing tests - 9 billion chickens processed in the U.S. per year 
• Meat Industry - currently performing tests - 145,000 head of cattle processed per day in the U.S., 290,000 pigs
Seafood Market - currently performing tests 

Selected Financial Highlights

Shares Outstanding: 27,116,512 (as of 06-30-02) 
Estimated Market Cap: 29.8M (as of 02-04-03) 
State of Incorporation: Florida
Business History: Company was formerly = October Project II Corp., until September 2000.
Transfer Agent: Interwest Transfer Co., Inc., Salt Lake City, UT 84117
Legal Counsel: Kramer Levin Naftalis & Frankel LLP
Certified Public Accounting Firm: Pender Newkirk & Company

Please Note* Commencing in the first quarter of 2003, NCCL plans to report its financial results on a quarterly basis.

Disclaimer: StockUpTicks.com is a property of Market Pathways Financial Relations Incorporated (MP).  The information, opinions and analysis contained herein are based on sources believed to be reliable but no representation, expressed or implied, is made as to its accuracy, completeness or correctness.  Past performance is no guarantee of future results. This report is a paid advertisement and is for information purposes only and should not be used as the basis for any investment decision. MP has been paid $10,000 by KZS Marketing for preparation and distribution of this report and other advertising services. This constitutes a conflict of interest as to MP’s ability to remain objective in its communication regarding the subject company.  Write or call MP for detailed disclosure as required by Rule 17b of the Securities Act of 1933/1934.  MP is not an investment advisor and this report is not investment advice. This information is neither a solicitation to buy nor an offer to sell securities but is a paid advertisement.  Information contained herein contains forward-looking statements and is subject to significant risks and uncertainties, which will affect the results.  The opinions contained herein reflect our current judgment and are subject to change without notice. MP and/or its affiliates, associates and employees from time to time may have either a long or short position in securities mentioned.  Information contained herein may not be reproduced in whole or in part without the express written consent of Market Pathways Financial Relations Incorporated.